WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

REVIEW ARTICLE: TRANSDERMAL DRUG DELIVERY SYSTEM

Dr. Varsha M. Jadhav*, Dr. Vilasrao Kadam, Ms. Manasi S. Mehetar, Ms. Dipali D. Suryawanshi, Ms. Pratiksha G. Patil, Ms. Samruddhi R. Nale, Ms. Sunayana R. Sable

ABSTRACT

Transdermal drug delivery has made an important contribution to medical practice, a transdermal patch is a medicated adhesive patch that is placed on the derma to deliver a specific dose through the skin into systemic circulation. An advantage of a TDDS over other types of delivery system such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main aim of transdermal drug delivery system is to deliver drugs into systemic circulation through skin at predetermined rate with minimal inter and intrapatient variations. During the past few years, attentiveness in the growth of novel drug delivery systems for existing drug molecules has been renewed. The growth of a novel delivery system for existing drug molecules not only upgrade the drug‟s performance in terms of efficacy and safety but also upgrade patient compliance and overall therapeutic benefit to a significant extent. To overcome difficulties in conventional dosage forms, a novel drug delivery system was developed (Chien, 1992; Banker, 1990; Guy, 1996). The impetus for the growth of novel drug delivery systems, aside from therapeutic efficacy is cost. Re-designing the modules and means to convey medicine into the body is a less challenging and more lucrative task. To address these problems, a controlled release drug delivery system, a novel drug delivery approach evolves, which facilitates the drug release into systemic circulation at a pre-determined rate. Controlled drug release can be achieved by transdermal drug delivery systems (TDDS) Transdermal drug delivery system is topically administered medicaments and deliver medicines via the skin portal to systemic circulation at a pre-established rate over a prolonged period. Transdermal Drug Delivery System (TDDS) are defined as self-contained, discrete dosage forms. [1]

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More